Sunday, March 26, 2017

Acetyl-dl-leucine for some forms of degenerative cerebellar ataxia

Acetyl-dl-leucine

Supplementation with the amino acid acetyl-dl-leucine may offer benefits for some forms of degenerative cerebellar ataxia.

In a clinical trial, published in the October 2013 issue of the Journal of Neurology, participants consumed 5 grams of acetyl-dl-leucine per day for 1 week11.

Researchers reported an average of 20 percent decrease in scores on an ataxia rating scale. Gait coordination and speed, speech, and hand and finger dexterity all showed improvement. No adverse side effects occurred, implying a good risk-to-benefit profile for acetyl-dl-leucine

Https://www.multiplesystematrophy.org/about-msa/cerebellar-ataxia-non-pharm

No comments: